Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The one thing that everyone must take notice of is the fact that we are asking for HIGHER royalties. How can this be a bad thing? It only emphasizes the fact that RECAF is ready and it works. The only hold up is clinical trials and if we have to do this with Inverness you will pay us us for not living up to your end of the contract.
When I called I was told that he was in Europe (not on vacation) I believe this to be true. It is my fault for not following up by calling again.
By renegotiating, Dr Moro is not just opening more doors, but he is opening all the windows as well. He has finally realized he must now get this into the hands of all institutions and academia (for a price). This is a turning point for the company. He is finally doing what we wanted him to do for quite some time. He is standing up for shareholders and screaming loudly that he knows that it is time to get the rest of the world to put RECAF to the test and see for themselves that he has found the Holy Grail. There will be skepticism about what has recently transpired, but Dr Moro is laying it all on the line, and if you still trust the results of RECAF you won't mistake the press release as a bad thing.
Dr Moro said let's put the peddle to the metal and we will finish what we started. He finally couldn't take it and was waiting for a better partner. We got one, so now he has the power to renegotiate. I'm a little nervous, but I feel it was the correct move. I know Inverness is smiling right now.
Now reread the press release.
The timing was just before the $50,000 payment was due. He said no way. No more free rides. We have continued to do our part and you have not done your fair share, so IMO he has learned from his mistake that he should have negotiated larger upfront payments to give them the incentive to carry thru with their obligations. Now that he partnered with Inverness we will shortly see that I am correct in assuming he received a larger upfront payment and has the cash to carry us thru. Since Abbott has contributed little Dr Moro feels it is in the best interest to the company and to shareholders to renegotiate the terms that reflect all of our hard work. No one returned anything or dropped us. This was an ultimatum to Abbott. He has thrown the ball over to them and now says let's just see how committed you really are. Yes it is ballsy, but Dr Moro has lost his patience.
I say good for Dr Moro and good for shareholders. Dr Moro finally stood up and said we are done doing all the heavy lifting, so keep your $50,000 royalty payment and pay us a higher royalty since we have done all the work anyway. This was initiated by Dr Moro. HE WANTS BETTER TERMS. If they respond negatively then we are dealing with a different situation.
Where else could the money be coming from? I would rather see a new licensee on the horizon. I was told he has turned down offers from smaller companies, and he wants another major company to complete the trio.
IMO, the extra cash is from Inverness, because of a larger upfront payment. We will all see shortly. There has been alot of traveling on Dr Moro's part recently and it has always been business related (unless he is setting up a Swiss bank account). IMO, I am in concensus and we are getting close to payday.
Is that a rehashed article or is it new?
Interesting to see that during the most recent conference call Inverness spoke about working with Biocurex without mentioning our name directly. I can't help thinking about where this stock would be if Abbott and Inverness would speak about Biocurex as a company instead of a potential new biomarker. Here's an excerpt of the conference call. Read thru till you see what I mean.
* We held a conference call with Ron Zwanziger and Ron
Geraty of Inverness Medical management, focused specifically on the
company's controversial Disease Management strategy.
* Geraty stated clearly that IMA's intention was to offer better, faster, more
convenient, cheaper health care solutions, and Disease Management products/
services that lead to lower mortality rates.
* We found management's enthusiasm and conviction for its Disease Management
offering to be readily apparent, though specifics of the strategy are still
lacking for the most part. As a result, while we believe IMA's strategy is
well thought out, it appears to be coming across to investors as simply a
more ambitious approach to a traditional Disease Management offering rather
than something truly revolutionary, in our view.
* We believe some of this is timing related. IMA management has indicated
repeatedly that it would have preferred to wait at least another year or so
before acquiring Matria, though chose to move early when MATR put the
company up for sale. We believe IMA will be better positioned to show the
true intention of its DM strategy 12 months from now. For example, IMA
management indicated that they are currently rolling out a home rapid
diagnostic program to a selected population of patients with a major client.
In addition, Geraty confirmed that IMA is working with another major client
in a pilot study to test the usefulness of a new biomarker.
From To
Changes (Previous) (Current)
------------------------- ------------------------- -------------------------
Rating -- Buy
Target Price -- $56.00
FY08E EPS (Net) -- $2.03
FY09E EPS (Net) -- $2.80
Anyone notice that it is getting harder to scoop up more shares at these levels? Terry's last conversation was that they hired someone with significant contacts to get the proper media coverage we were all hoping for. I thought he said her name was Pat. He also said that we would no longer publish with any of the worthless penny rag newsletters. He agreed that it is beneath us to go to those letters at this point when we have such a promising future.
We don't know the details of the Inverness license, but I assume they are in line with the Abbott deal. However, they could have gotten a larger upfront payment knowing that much of the "dirty work" has been completed. That is my hunch. If so, we will get by.
Dr Moro obviously expected approval much sooner. Remember he said he was done with the diagnostic portion of Recaf and was moving on to other applications, so he felt that he had provided proper guidance and instructions on the detection of cancer, so he wasted no more time. He is just as anxious as we are, probably more so. Bottom line.... he expected or expects approval very soon. I hope so.
The whole deal with Smithline makes no sense. Why would you borrow money to pay back the money you owe the person you just borrowed from. It is like asking for change for a dollar and using that change and then paying them a 50% service charge. However, the big picture reveals a royalty payment much larger that will more than offset any larger upfront payment, and that is why Dr Moro has been biting the bullet up to this point.
Is it possible they will get European approval prior to US? They seem to be way ahead of the curve as far as approvals for new drugs.
Interesting to reread that press release. The highlights I get from this are the following:
1)The results obtained with the assay format used in several automated instruments including the Abbott ArchitectTM. 68 breast, gastric and other types of cancers were compared to 52 normal patients and the AUC scoring obtained was 0.954 (a perfect discrimination between cancer and normal samples has a score of 1.0). Similar results were independently obtained in Abbott’s facility for prostate cancer samples.
TOTAL 120 samples. Anyone venture a guess as to how many samples are required for the 510K?
2)The second study was done in collaboration with Abbott and the University of Munich to determine the best type of specimen collecting tube for RECAF testing in a clinical laboratory environment which appears to have been completed.
The key elements are that this is independent of Biocurex, done in a clinical laboratory environment BY ABBOTT WITH THE UNIVERSITY OF MUNICH. It is required by the FDA to show that the test could perform in a clinical setting.
Dr Moro just returned from Munich. Coincidence? I think not.
Quote..."We are getting closer and closer to the commercialization of a cancer test that has the potential to be used for screening patients in much the same way a blood sugar or cholesterol reading is requested as part of a routine blood test."
IMO, we are setting up for some good news shortly. Dr Moro has created this beautiful diamond and now he is just polishing it up for the rest of the world to see. He must make sure that it is as close to flawless, because there are no second chances.
Thanks GG, it is definitely worth a second look.
I remember we pieced together the ISOBM before it was announced and the pieces of the puzzle are starting to come together once again setting us up for some great things in our future.
I'm here. I'll continue being patient. No comment from management, but I sense we are on the cusp of something meaningful, and that is the holdup on the update.
Found 2 new links:
http://new.reillycomm.com/imaging/special-report2.php?id=526
http://www.levinassociates.com/publications/mam/mamheadlines/08mamhead/802mamhead.htm
All I know is Dr Moro is away on business related to Recaf. I can only speculate, but I know it's a good thing. Keep the faith.
Obviously you don't see the share price as a concern. I do. You also may not have been involved on a personal basis with Dr Moro. I thought I was. He was very happy to talk to me about taking a substantial amount of my money, but now that he has it he did not call. I did not mention I have tried 2 other times in the Fall of last year and left voicemails ....no response. I may be blowing off steam here, but I think he owes it to me. I was only including everyone else here, because they share the same concerns and want some answers. The point is NO response isn't justified. I'll leave it that.
This is like a big cocktail party. There is nothing but opinions being formed here and nothing can be taken at face value unless it was substantiated by a proven source. Therefore, we should all take a deep breath and realize that trust is the issue. I trust the technology works and because I am an entrepreneur myself I have a tendency to step into their shoes and say to myself, "why don't they do this? or say that? or negotiate a certain way?" I did not want to stir the pot, but all my posts are just my thoughts and my opinions just like all other contributors. My intentions are to only help this company succeed. I still think they should give us an update and I'll leave it at that.
There is too much speculation. Speculation leads to uncertainty. Uncertainty leads to lower share price. I hope we get some answers soon or a definitive response such as.... because of our licensing contracts we are unable to speak openly about trials, but things are progressing. That's all we need to know. It clears the air. Their biggest blunder was allowing both Abbott and Inverness to not even mention BioCurex or Recaf anywhere on their website. Their names are attached to OUR press releases and this has a totally different impact, and attracts no new investors. It only excites exisisting shareholders. Having Inverness acknowledge our deal appropriately would have catapulted us to several dollars and we would have increased volume and able to maintain a respectable share price. With the share price this low it creates doubts. When we get clarity we will have many shareholders adding to their position at these levels.
I must comment that I am insulted that I did not hear back from Dr Moro. I have been one of of his most loyal supporters and stuck by him well before the Abbott deal. I am also one of their largest shareholders, so it was surprising I did not get a simple response. We'll see what Monday brings.
Goodmorning. First, I would like to thank everyone for supporting my ideas. I am sorry to report Dr Moro did not return my call, but I feel I definitely opened his eyes to the situation at hand.
We all have been thinking the same thoughts and share the same concerns. It has been a long time coming. I have no intentions to go on the attack, but their disregard toward shareholders has not previously been recognized by them as a concern.
All we are asking for is answers to basic questions. Once they realize that we have EVERYONE'S best interest at heart (especially Dr Moro) they will look back and say that it was foolish they didn't update us sooner. It was only this week after hearing the same old song and dance that we will be getting an update shortly that never seemed to appear, that I felt this had gone on long enough.
I understand Dr Moro has focused all of his energy into Recaf, and I as well as most others, feel that he will be recognized by his peers as a brilliant scientist and will receive a Nobel Prize for his contributions toward diagnosing early cancer as well as finding a cure. If any of you ever had the opportunity to speak with him you would instantly be impressed with his knowledge, and you would know that we are all very fortunate to be a part of this company. My intention is not to rock the boat or steer his attention away from the lab. I want him to delegate with authority and allow us to prosper by surrounding himself with other visionaries that will help him to succeed.
I am sure that this is only an oversight, because this has been their pattern of distributing information. I know he is perplexed by the share price and has no idea how irate and frustrated shareholders are, or he would have responded without me having to call his attention to the situation.
I hope he is mulling over what steps will be necessary to regain our confidence and will respond by Monday. He has my phone #. I made sure of it. I will be more than happy to ask the questions we all want answered, and like I said earlier, it will result in a much stronger company.
Let's not forget that we have the only UNIVERSAL cancer marker, and it is a major piece of the puzzle in finding a cure for cancer. We will help them continue to get the word out and by seeing more and more information disseminated we will create a strong interest from investors, scientists, and the national media. We will be a worldwide corporation with Recaf being used in every country.
I will keep everyone abreast to the situation. I am excited and encouraged by what is happening. Let's see what happens Monday. Thanks for supporting me.
I am stepping out, but gave Dr Moro my cell phone #. I will let everyone know if he responds. I want everyone to know I am not attacking management, only letting them know that we need them to react appropriately toward shareholders. By the way I am so sure they will react positively that I bought more shares today. We won't be at these levels much longer.
Ther train has left the station. I called Terry first to discuss the situation. I then called BioCurex and Dr Moro is in a meeting, Antonia is out till Monday, and Wittenberg is not at BioCurex offices (go figure!). I am expecting a call from Dr Moro hopefully today. This is what I want to discuss:
1)Why no updates?
2)Why is there no mention of us on Abbott or Inverness's website?
3)Why is there no attempt to get proper media coverage?
4)What happened to Imaging, Goshen, or Bhlokin?
5)Why aren't you enforcing our patents against Innexus, and others using our patented technology?
6)Why do you continue to list us under Whispering Oaks?
7)Why don't you participate at more oncology conferences?
8)Why is there a Recaf.com? I thought we have the name trademarked.
9)When will you pay off the hedgefund which has caused us major dilution and obvious stock price manipulation?
10)Why aren't we getting proper media coverage on the web, in print, or on television?
11)How can you expect your CFO to practice dentistry and direct the company in a proper manner?
Anything more from anyone on this board now is your time to speak out. We are at a cross roads and it will all be for the better.
Today is the last day for the hedgefund to manipulate the share price. I am going to take the speculation out of this stock and get us back to a respectable share price. I want a shareholder update at minimum and I will propose a conference call or a scheduled date for shareholders to have a meeting with management. If they have been working hard on promoting us in other ways than penny newsletters, then now is the time to respond. If not, we need someone in charge who has a vested interest, not just collecting free shares.
I just read that and here is another opportunity for management to capitalize. If that pathologist can see with his own eyes he would rally along side us and he would send a message that Recaf IS viable and we would get the kind of investors that would be interested in a long term investment. If management has an opportunity like this I would invite him to the lab, send him all of our research, and give him whatever he needs to test Recaf. He in turn would publish his results and we would get free media coverage. It is time to step up to the plate. I would want management to respond to everyone in this manner. I had mentioned the importance of having Dr Moro attend more scientific meetings. Now you see why I feel this is a critical part of the equation. No one knows the story, and the most popular response is why? That is why we need to do better and we can do better. I just don't see any effort being made, so it is not up to the shareholders to alert the media so Wittenberg could keep practicing.
What is meant is that I don't have an edge. We are all in this together and everyone benefits from what I am proposing. You don't have to question my motives, they are in response to my disappointment to what has happened to the share price. My frustration comes from the fact that they don't realize that by not sending out a message they ARE sending out a message.
Motley fool wants to see earnings, so they are on the sidelines.
I chose not to go to their offices, but I regret that decision. I get the same information as the rest of you, and lucky for all of you that has been the case. Everyone hear will benefit from my efforts and this is only fair. The lack of communication is why I am on this board. I have found that over the years it has been very useful to at least get some information that is worth while. This board should not be for those purposes. It should be more of a scoreboard on what we like and what we dislike, but this has been the only place to find out any information whatsoever. That sends up a red flad immediately. Then I find out that our CFO is still practicing oral surgery and has a history of using shareholder money and our shares to pay for worthless penny newsletters instead of contacting any of the cancer research centers or media to get us significant media coverage. I'm tired of calling and begging for some glimpse at where this company is going. It is finally time after the Inverness deal to answer some of our questions. I fully understand that there obviously are limits to what can and cannot be said, but saying nothing has caused severe psychological damage to this stock. There are fundamental issues that that can easily be resolved by giving shareholders an opportunity to be heard. Again, we all benefit, so what is the hangup? I just don't get it. I'm not on a rant. I am strictly doing this to this because it is time the rest of the world knows about BioCurex. I want to see what they are doing to increase shareholder value. I'm sick of further dilution with no help to the share price. If there is a method to your madness it now time to share this strategy with your shareholders. We are not impressed and we will be calling for changes.
What management should take note of is that today alone I have noticed more shareholders beginning to come out of the woodwork that obviously pay attention to what is being said on this board and they never contributed before, but they too, see what I have been saying has sparked them to respond. They have the same questions I do, but until I said I would finally take action to this they came to this site to get whatever information we could give them. This has become a very powerful source of information and there are more shareholders that read this than you think. It will have an affect on how this is received by management. The answer I have gotten by management is we can't control the share price, but they certainly can make an effort to send out regularly scheduled updates.
I don't want to go at this alone, however, I own enough shares that they will consider what I say. I never thought I would have to tell them what they are doing wrong, but like I said, I have alot at stake and I am finished with them not responding. I keep hearing about all the great things going on, but now it's time to see it in print.
Gyro, I definitely appreciate your involvement, and as you may have guessed I just hit the send button. I certainly respect your input and there certainly wasn't any malice directed toward you. I am glad you asked for my clarification.
Back to the business at hand. They are 3 hours earlier there in Vancouver. I know factually that this board is read at BioCurex. They shouldn't be stunned by my remarks. This has been a long time comming. I just kept giving them the benefit of the doubt, but enough is enough. I don't like having to speculate on my investment. I thought we turned the corner with the Inverness deal, but with the share price drifting lower I won't allow this to continue. I feel I am being punished as well as every other investor because of this total lack communication. If we don't do something we will continue lower. On the other hand, if we get that update and be allowed to participate in the direction of this company we will prosper.
I will make sure that we are successful in this endeavor. It will only result in stock price appreciation and we will eventually be able to snuff out the hedge fund when thy will no longer be able to manipulate the share price because we will have much higher volume to contend with. If they are regularly spaced we will maintain this higher level and we will all benefit in the long run.
It is like we are all hungry so their solution is to have one big feast every couple of months and everyone is content and satisfied, but slowly we become hungry again and that hunger builds to famine and starvation and eventually death. Then after many deaths they decide to have another feast so we all don't die. All I am suggesting is they feed us all a little bit at a time and we all will prosper and every once in awhile that feast would be even more special. I have a successful business and I know the importance of using logic, putting yourself in other people's shoes to get their perspective, and especially, number one, surrounding yourself with the best people you can find. I see none of this here and if we force this to change, I promise this will be a major biotech company. The science is like no other and it has been validated. The share price is strictly a reflection on management, not the science. If we fix management we all be extremely rewarded. I don't want to see this fail because it was mismanaged. There is no reason why we can't see us get back to share price that reflects our true worth. I will see this thru. You will all benefit, but again, anyone with a large investment such as myself, this is your opportunity to get involved. Strength in numbers. I don't see this as a distraction for them, but a chance to get us back on track with investors.
If we don't get an update I will band together as many shareholders as I can and I will force you to. I really expected to see something today. I will get your attention by any means possible. I and many others have too much at stake to allow you to turn your backs on us. I spoke with Terry and I don't know what the hold up is. Obviously, because of your disregard, you are not fit to run this company. I never heard of someone running a biotech company as a side job. The shareholders have been patient and you continue to bite the hand that feeds you. You know who I am, and I know that you read this. I am a MAJOR shareholder not to be taken lightly. These are my thoughts as well as everyone elses'. I won't back down until you get the message loud and clear. I feel I have suffered losses as well as every other shareholder, and I feel that absolutely, unequivocally, we would not be this low if you kept us informed of your progress. You have left too many questions unanswered. You are too busy or it cost too much money is not an excuse after throwing out money on penny newsletters and finding out you spend your days practicing oral surgery. Before you issue yourself any more free options I would suggest you send out that update.
Welcome Apollo and I'm sure there are many others on this board that have been anonymous. It is absolutely necessary to have as many of us comment here about the poor job of shareholder relations. I am determined to force them to come to the realization that it is detrimental to the future of this company to ignore its shareholders. I've said it many times that I have put my money where my mouth is, and I have no quams about calling BioCurex. None of us would be here or hold onto one share of this stock if we didn't believe in the technology.
I would suggest you go back quite a ways in our posts and you will reveal the answers to many of your questions. I only say this for fear of repeating myself, but in summary, for the most part, most longs are 2 thumbs up on the technology and 2 thumbs down on management. We hope that the technology will be approved shortly after Abbott or Inverness get thru whatever trials are necessary. Then we will be rewarded by a significant move in the share price. We will move higher in the interim only if we are given an update. The only one that is selling is the hedge fund that is doing their best to keep us under .70 cents for some reason.
As far as what the share price will be is only speculation. If you ask anyone on this board, though, they would tell you that this is probably a opportunity worth the risk.
If we don't get an update tomorrow or the latest Monday, I will be on a plane shortly and I'm bringing my friend, Mr. Trump. It would not make one bit of difference if Wittenberg was gone. He is a ghost. He writes himself a blank check for options and then he is off to the oral surgery practice. There is no justice for shareholders. This is a crime. There is no way to justify millions of shares when has done nothing to elevate the share price. In a legitimate company there is a board of directors. Wittenberg would have no problem with me if the share price was respectable.
Just by the share price alone it reflects on his inability to attract new investors. When I tell anyone about Recaf they are interested in what I have to say, but then I find myself defending the low share price. It sends the wrong signal. I've said it many times it is management's report card and they are failing.
I called many times and explained the necessity for regular shareholder updates. They say it is coming. I'll believe it when I see it. If it never comes it wasn't from lack of me pleading with them. I seem to be the only one who feels it is important to just keep us abreast of anything new or on the horizon.
If wittenberg is too busy pulling teeth then fire his a** and get someone in there who cares. I'm tired of searching the internet and calling Terry. My patience is wearing thin. This is not the time in the market to avoid shareholders.
Dilution and share price manipulation is not savvy. I don't want to sound like I am attacking you, but that is my opinion.
That was their idea of a shareholder update. Wittenberg, expect a call from Mr. Trump.
I wish it was management!
10Q is a xerox copy. This bus is moving except the driver is asleep at the wheel.
What is up with this? Recaf is copyrighted,
http://www.recaf.com/Competent_E_Coli_Cells.php?domain_name=RECAF.COM&rx=Competent+E+Coli+Cells
So far we have other companies using our receptor to find a cure and now we a have another company using our copyrighted name for a website for another biotech company. Hello, is everyone at BioCurex on vacation or are they just out to lunch?
Dr Moro is not screaming. He goes to one oncology meeting a year. I don't want to criticize his accomplishments. I hold him in the highest regard. If I didn't trust or believe in him I would have bailed after the SEC debacle. I spoke to him a few times and he is a very brilliant man. He is the only reason I have faith in this company. I can only say I am disappointed that he still feels that he can effectively do the science and run the company at the same time. Collectively, this board has done more to get the word out or at least up to this point we have made an effort.
Dr Moro is a gifted problem solver. Unfortunately for us, he doesn't see the share price falling because of lack of communication with his shareholders as a problem. If it stems from not knowing what he can and can't say to flag the SEC, then contact them and ask.
There are 2 things right off the bat that will reinvigorate investors: 1) shareholder update. 2) a presentation at more oncology meetings.
There is no reason we couldn't see both. That would make me very content shareholder.
We should all be dancing on clouds if they would only share their enthusiasm. I know what the problem is. They are content knowing what they know and feel that the share price will take care of itself. That is why they need experience to show them the way it's done properly in the corporate world. If we start at a base of under a dollar we build off that and it takes much longer to gain stock appreciation on a percentage basis. If we start at a base of a 2 or 3 dollars we can build off that and go much higher faster. It is like we are bleeding and they don't care because they figure we will get a transfusion at some point. It is a HUGE financial mistake not to update your shareholders. We should be on here excited not frustrated and it would go a long way toward goodwill. SHAZAM!!! That word has an entirely different meaning to me now. It means waste of money.